Figure 2.
MicroRNA expression patterns in neural stem cell models of gene dosage disorders are more characteristic of differentiating non-target cells than proliferating non-target cells. (a) NanoString expression values for all microRNA with single point P-values <0.05 in the MBD5 KD experiment compared with non-target proliferating cells. (b) NanoString expression values for the same microRNAs identified in the MBD5 KD experiment but showing values for the cell state (differentiating non-target cells compared with proliferating non-target cells) experiment. (c and d) Quantitative PCR (qPCR) validation of two microRNAs identified in the MBD5 KD experiment. (e) NanoString expression values for all microRNA with single point P-values <0.05 in the SATB2 KD experiment (f) NanoString expression values for the same microRNAs identified in the SATB2 KD experiment, but showing values for the cell state (differentiating non-target cells compared with proliferating non-target cells) experiment. (g and h) qPCR validation of two microRNAs identified in the SATB2 KD experiment. (i) Distribution of microRNAs that are up- or downregulated in the cell state experiment plotted as a function of P-value. KD, knockdown; MBD, methyl-CpG binding domain; SATB, special AT-rich binding protein.